YXYong Xi

Yong Xi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yong Xi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Chengbin Lin

    Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315040, China

    3 shared publications
  • Hongyan Yu

    Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315040, China

    3 shared publications
  • Weiyu Shen

    Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315040, China

    2 shared publications
  • Xiaohan Chen

    Ningbo Univ, Affiliated Lihuili Hosp, Dept Thorac Surg, Ningbo, Peoples R China

    2 shared publications
  • Chenghua Jin

    Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo City, Zhejiang Province, P.R. China

    1 shared publication
  • Lijie Chen

    School of Medicine, Xiamen University, Xiamen 361102, Fujian, China; China Medical University, Shenyang 110122, Liaoning, China

    1 shared publication

Latest Publications

  • Open Access

    circRNA TCFL5 Promote Esophageal Cancer Progression by Modulating M2 Macrophage Polarization via the miR-543-FMNL2 Axis

    by Chengbin Lin, Yong Xi, Hongyan Yu, Zheng Wang, Xiaohan Chen, Weiyu Shen

    Objective. The mechanism of circRNA on M2 macrophage polarization, which contributes to esophageal cancer, remains unclear. This study is aimed at clarifying the mechanism of circRNA on esophageal cancer by regulating M2 macrophage polarization. Methods. The expression of circRNA TCFL5 and miR-543 was detected by qRT-PCR. Western blot was used to detect the expression of FMNL2 and CD163. CCK-8 and transwell assay was used to detect the proliferation, migration, and invasion of Eca109 and KYSE150, respectively. Flow cytometry was used to detect the CD163 positive cells. The contents of IL-10, TGF-β, TNF-α, IL-6, and IL-1β were detected by ELISA. A dual-luciferase reporter system was used to detect the regulation of miR-543 to circRNA TCFL5 and FMNL2. Results. 156 upregulated circRNAs and 91 downregulated circRNAs in esophageal cancer tissues were identified, and the expression of circRNA TCFL5 showed the most significant upregulation. Overexpression of circRNA TCFL5 promotes proliferation, invasion, and migration of Eca109 and KYSE150 and promotes tumor growth in vivo. circRNA TCFL5 served as a sponge of miR-543, and FMNL2 was a downstream target gene of miR-543. circRNA TCFL5 promotes cell proliferation, migration, and invasion of Eca109 and KYSE150 by modulating the miR-543/FMNL2 axis. Macrophage M2 polarization promoted proliferation, invasion, and migration of Eca109 and KYSE150 cells, and circRNA TCFL5 mediated macrophage M2 polarization by regulating the FMNL2/miR-543 axis. Conclusion. In the present study, we identified that circRNA TCFL5 was dramatically upregulated in esophageal cancer, and circRNA TCFL5 promotes esophageal cancer progression by modulating M2 macrophage polarization via the miR-543-FMNL2 axis, which provides a potential target for the treatment of esophageal cancer.


  • Open Access

    Prognostic value of an immunohistochemical signature in patients with pulmonary squamous cell carcinoma undergoing complete surgical resection

    by Chengbin Lin, Yong Xi, Hongyan Yu, Xiaohan Chen, Weiyu Shen

    Background: The Tumor Node Metastasis (TNM) stage cannot accurately predict the prognosis of patients in pulmonary squamous cell carcinoma (SQCC). The aim of the present study was to evaluate the prognostic value of immunohistochemical (IHC)-based classifiers in patients with pulmonary SQCC who underwent complete surgery resection. Methods: From January 2010 to December 2014, a total of 556 patients with SQCC who underwent complete radical resection were included. The patients were grouped into a discovery group (n=334) and a validation group (n=222). Using the least absolute shrinkage and selection operator (LASSO) regression model, we extracted IHCs that were associated with progression-free survival (PFS) and then built classifiers. Clinicopathological variables and the IHC-based classifiers were analyzed using univariable and multivariable logistic regression analyses. A nomogram to predict PFS was constructed and validated using bootstrap resampling. Results: Following the LASSO regression model, 4 IHC markers associated with PFS were identified. We used the IHC-based classifiers to stratify patients in both groups into high- and low-risk groups. PFS was better in the low-risk group than in the high-risk group in both the discovery and validation groups. Multivariate analysis demonstrated that the IHC-based classifiers were independently prognostic in predicting the PFS of patients with SQCC. The performance of the nomogram was evaluated and proven to be clinically useful. Conclusions: By combining IHC-based classification and clinicopathology, we were able to have better insight into the prognostic assessment of patients with SQCC after surgery, which can inform postoperative patient management.


  • Open Access

    Immunohistochemical Signatures as Predictors of Postsurgical Prognosis in Pulmonary Squamous Cell Carcinoma Patients

    by Chengbin Lin, Hongyan Yu, Xiaohan Chen, Weiyu Shen, Yong Xi

    BackgroundWe aimed to evaluate the prognostic value of immunohistochemistry (IHC) markers and tumor-node-metastasis (TNM) stages in patients with pulmonary squamous cell carcinoma (SQCC). MethodsFrom January 2010 to December 2014, aA total of 556 patients with SQCC who underwent radical resection were included. The patients were grouped into a discovery group (n = 334) and a validation group (n = 222). Using the least absolute shrinkage and selection operator regression model, we extracted IHCs that were associated with progression-free survival (PFS) and then built a classifier. Clinicopathologic variables and the IHC-based classifier were analysed using univariable and multivariable logistic regression analysis. A nomogram to predict PFS was constructed and validated using bootstrap resampling.ResultsFollowingUsing the least absolute shrinkage and selection operator regression model, four IHC markers associated with progression-free survival (PFS) were identified. Furthermore, we developed a nomogram integrating IHC markers to predict 3- and 5-year PFS. We used the IHC-based classifiers to stratify patients in both groups into high- and low-risk groups. PFS was better in the low-risk group than in the high-risk group in both the discovery and validation groups. Multivariate analysis demonstrated that the IHC-based classifiers were independently prognostic in predicting the PFS of patients with SQCC. The performance of the nomogram was evaluated and proven to be clinically useful. ConclusionsWe further developed a nomogram integrating the IHC-based classifiers and clinicopathological risk factors to predict PFS. Through combining the IHC-based classification and clinicopathology, we have a better insight into the prognosis assessment of patients with SQCC after surgery, which informs postoperative patient management.

  • LncRNA PSMG3AS1 promotes proliferation of non-small cell lung cancer cells by sponging miR-613 to upregulate SphK1

    by Weiyu Shen, Xunyu Hong, Chenghua Jin, Yong Xi

    PSMG3-AS1 is a characterized oncogenic lncRNA in breast cancer, while its role in other cancers remains unclear. This study was to investigate the role and underlying mechansim of PSMG3-AS1 in non-small cell lung cancer (NSCLC). In this study, we found that PSMG3-AS1 could interact with miR-613. The expression of PSMG3-AS1 was upregulated in NSCLC, while the expression of miR-613 was downregulated in NSCLC. However, PSMG3-AS1 and miR-613 were not significantly correlated with each other. In NSCLC cells, PSMG3-AS1 and miR-613 overexpression failed to regulate the expression of each other. Interestingly, PSMG3-AS1 overexpression led to upregulated SphK1, a downstream target of miR-613. In addition, PSMG3-AS1 overexpression reduced the inhibitory effects of miR-613 on NSCLC cell proliferation. Therefore, PSMG3-AS1 may promote the proliferation of NSCLC cells by sponging miR-613 to upregulate SphK1.